Related Experiment Video
Updated: Apr 27, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Interleukin-6 in renal disease and therapy
Simon A Jones1, Donald J Fraser2, Ceri A Fielding3
1Cardiff Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff University, Cardiff, Wales, UK jonessa@cardiff.ac.uk.
Interleukin-6 (IL-6) plays a key role in autoimmune diseases and renal complications. Blocking IL-6 offers a promising therapeutic strategy for patients with kidney disease.
Area of Science:
- Immunology
- Nephrology
- Rheumatology
Background:
- Interleukin-6 (IL-6) is implicated in autoimmune conditions.
- Anti-IL-6 therapies like tocilizumab highlight IL-6's role in disease progression.
- IL-6 is linked to adverse outcomes in renal disease.
Purpose of the Study:
- To review the biology of IL-6.
- To discuss IL-6's impact on renal disease and associated complications.
- To evaluate IL-6 as a prognostic marker and explore IL-6-blocking therapies in nephrology.
Main Methods:
- Literature review of IL-6 biology and its role in renal disease.
- Analysis of clinical data on IL-6 in renal replacement therapy and transplantation.
- Evaluation of prognostic value of IL-6 and efficacy of IL-6 inhibitors.
Main Results:
- IL-6 is a significant driver of autoimmune conditions and renal disease.
- Elevated IL-6 levels correlate with poor outcomes in renal replacement therapy and transplantation.
- IL-6 measurement shows potential as a prognostic indicator.
Conclusions:
- IL-6 is a critical factor in renal disease pathogenesis and complications.
- Targeting IL-6 with therapies like tocilizumab is a viable strategy for renal patients.
- Further research into IL-6-blocking agents in nephrology is warranted.
Related Concept Videos
Acute Kidney Injury VI: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management

